SCHEMBL8549601

SCHEMBL8549601

O=C(c1cccc(F)c1)C(Br)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 3/20 0.61
CES1 P23141 3/20 0.61
PARP1 P09874 1/20 0.49
PKM P14618 1/20 0.48
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
KCNK3 O14649 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
ALDH1A1 P00352 2/20 0.46
GPR139 Q6DWJ6 1/20 0.46
LMNA P02545 1/20 0.46
GAA P10253 1/20 0.46
CHRNB2 P17787 1/20 0.46
SLC6A2 P23975 1/20 0.46
CHRNB4 P30926 1/20 0.46
CHRNA3 P32297 1/20 0.46
CHRNA4 P43681 1/20 0.46
SLC6A3 Q01959 1/20 0.46
NPC1 O15118 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL6285189 0.84 CES2 (0.51) CES2CES1PARP1KMT2AMEN1
SCHEMBL28795629 0.84 CES2 (0.58) CES2CES1PARP1PKMKMT2A
SCHEMBL7847640 0.82 CES2 (0.49) CES2CES1PARP1PKMKMT2A
SCHEMBL627867 0.82 CES2 (0.64) CES2CES1ALDH1A1LMNARAB9A
SCHEMBL23509648 0.81 ALDH1A1 (0.55) CES2CES1PARP1KMT2AMEN1
SCHEMBL18438933 0.81 CES2 (0.84) CES2CES1PARP1PKMKMT2A
SCHEMBL7215388 0.81 CA2 (0.54) CES2CES1PARP1ALDH1A1GAA
SCHEMBL1121616 0.81 LMNA (0.49) CES2CES1PKMKMT2AMEN1
SCHEMBL682581 0.81 CES2 (0.53) CES2CES1PKMKMT2AMEN1
SCHEMBL3362925 0.80 CES2 (0.61) CES2CES1PARP1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0825989-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-03-04 EP disclosed
WO-1996036617-A1 SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-11-21 WO disclosed